Molecular dynamics simulation study on the inhibitory effects of choline‐O‐sulfate on hIAPP protofibrilation

Type 2 diabetes mellitus (T2Dm) is a neurodegenerative disease, which occurs due to the self‐association of human islet amyloid polypeptide (hIAPP), also known as human amylin. It was reported experimentally that choline‐O‐sulfate (COS), a small organic molecule having a tertiary amino group and sulfate group, can prevent the aggregation of human amylin without providing the mechanism of the action of COS in the inhibition process. In this work, we investigate the influence of COS on the full‐length hIAPP peptide by performing 500 ns classical molecular dynamics simulations. From pure water simulation (without COS), we have identified the residues 11–20 and 23–36 that mainly participate in the fibril formation, but in the presence of 1.07 M COS these residues become totally free of β‐sheet conformation. Our results also show that the sulfate oxygen of COS directly interacts with the peptide backbone, which leads to the local disruption of peptide–peptide interaction. Moreover, the presence of favorable peptide‐COS vdW interaction energy and high coordination number of COS molecules in the first solvation shell of the peptide indicates the hydrophobic solvation of the peptide residues by COS molecules, which also play a crucial role in the prevention of β‐sheet formation. Finally, from the potential of mean force (PMFs) calculations, we observe that the free energy between two peptides is more negative in the absence of COS and with increasing concentration of COS, it becomes unfavorable significantly indicating that the peptide dimer formation is most stable in pure water, which becomes less favorable in the presence of COS. © 2019 Wiley Periodicals, Inc.

[1]  D. Raleigh,et al.  Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers , 2012, Protein science : a publication of the Protein Society.

[2]  Ruth Nussinov,et al.  Cross-seeding and Conformational Selection between Three- and Four-repeat Human Tau Proteins , 2012, The Journal of Biological Chemistry.

[3]  Mark E. Tuckerman,et al.  Reversible multiple time scale molecular dynamics , 1992 .

[4]  G. Bitan,et al.  Modulating Self‐Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and Mechanisms , 2012, ChemMedChem.

[5]  P. Lansbury,et al.  The structural basis of pancreatic amyloid formation : isotope-edited spectroscopy in the solid state , 1992 .

[6]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  P. Butler,et al.  Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. , 2008, Endocrine reviews.

[8]  Ueli Aebi,et al.  The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.

[9]  H. C. Andersen Rattle: A “velocity” version of the shake algorithm for molecular dynamics calculations , 1983 .

[10]  Guanghong Wei,et al.  Orcein-Related Small Molecule O4 Destabilizes hIAPP Protofibrils by Interacting Mostly with the Amyloidogenic Core Region. , 2017, The journal of physical chemistry. B.

[11]  Guizhao Liang,et al.  Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers. , 2013, Biochemistry.

[12]  Sandip Paul,et al.  Action of Caffeine as an Amyloid Inhibitor in the Aggregation of Aβ16-22 Peptides. , 2016, The journal of physical chemistry. B.

[13]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[14]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[15]  Eric Darve,et al.  Adaptive biasing force method for scalar and vector free energy calculations. , 2008, The Journal of chemical physics.

[16]  T. P. Davis,et al.  Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide. , 2017, Physical chemistry chemical physics : PCCP.

[17]  Guizhao Liang,et al.  Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions. , 2011, Biomacromolecules.

[18]  D. Raleigh,et al.  Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution , 2009, Proceedings of the National Academy of Sciences.

[19]  A. Schmidt,et al.  Mechanisms of islet amyloidosis toxicity in type 2 diabetes , 2013, FEBS letters.

[20]  Maarten F. M. Engel,et al.  Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus , 2008, Experimental diabetes research.

[21]  Yuxiang Mo,et al.  Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation , 2016, Scientific Reports.

[22]  David Eisenberg,et al.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.

[23]  Eric F Darve,et al.  Calculating free energies using average force , 2001 .

[24]  P. Lansbury In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. , 1992, Biochemistry.

[25]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[26]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[27]  A. Garcia,et al.  Characterization of Aβ Monomers through the Convergence of Ensemble Properties among Simulations with Multiple Force Fields. , 2016, The journal of physical chemistry. B.

[28]  Sandip Paul,et al.  How Does Aqueous Choline-O-Sulfate Solution Nullify the Action of Urea in Protein Denaturation? , 2018, J. Chem. Inf. Model..

[29]  A. Chandra Dynamical Behavior of Anion−Water and Water−Water Hydrogen Bonds in Aqueous Electrolyte Solutions: A Molecular Dynamics Study , 2003 .

[30]  Yan Sun,et al.  Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP. , 2014, The journal of physical chemistry. B.

[31]  Wenyu Lu,et al.  Brazilin inhibits fibrillogenesis of human islet amyloid polypeptide, disassembles mature fibrils, and alleviates cytotoxicity , 2017 .

[32]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[33]  Fanling Meng,et al.  The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. , 2010, Biochemistry.

[34]  U Aebi,et al.  Polymorphic fibrillar assembly of human amylin. , 1997, Journal of structural biology.

[35]  J. Bieschke Natural Compounds May Open New Routes to Treatment of Amyloid Diseases , 2013, Neurotherapeutics.

[36]  Ruth Nussinov,et al.  Conformational Basis for Asymmetric Seeding Barrier in Filaments of Three- and Four-Repeat Tau , 2012, Journal of the American Chemical Society.

[37]  Ian S. Haworth,et al.  Fibril Structure of Human Islet Amyloid Polypeptide*♦ , 2011, The Journal of Biological Chemistry.

[38]  D. Raleigh,et al.  Defining the Molecular Basis of Amyloid Inhibitors: Human Islet Amyloid Polypeptide–Insulin Interactions , 2014, Journal of the American Chemical Society.

[39]  Ruth Nussinov,et al.  Molecular insights into the reversible formation of tau protein fibrils. , 2013, Chemical communications.

[40]  A. Datta,et al.  Deciphering the Role of Solvents in the Liquid Phase Exfoliation of Hexagonal Boron Nitride: A Molecular Dynamics Simulation Study , 2017 .

[41]  Alexander D. MacKerell,et al.  Extension of the CHARMM general force field to sulfonyl‐containing compounds and its utility in biomolecular simulations , 2012, J. Comput. Chem..

[42]  A. Chandra,et al.  Hydrogen Bond Properties and Dynamics of Liquid-Vapor Interfaces of Aqueous Methanol Solutions. , 2005, Journal of Chemical Theory and Computation.

[43]  Ulrich H. E. Hansmann,et al.  Inter-Species Cross-Seeding: Stability and Assembly of Rat - Human Amylin Aggregates , 2014, PloS one.

[44]  Y. Mu,et al.  Assembly dynamics of two-beta sheets revealed by molecular dynamics simulations. , 2009, The Journal of chemical physics.

[45]  J. Bernhagen,et al.  Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.

[46]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[47]  Eric Darve,et al.  Calculating Free Energies Using a Scaled-Force Molecular Dynamics Algorithm , 2002 .

[48]  Hydrogen-bond dynamics near a micellar surface: origin of the universal slow relaxation at complex aqueous interfaces. , 2002, Physical review letters.

[49]  José Mario Martínez,et al.  PACKMOL: A package for building initial configurations for molecular dynamics simulations , 2009, J. Comput. Chem..

[50]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[51]  D. Raleigh,et al.  The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. , 2010, Journal of molecular biology.

[52]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[53]  A. Chandra,et al.  Hydrogen bond dynamics at vapour–water and metal–water interfaces , 2004 .

[54]  Chandra,et al.  Effects of ion atmosphere on hydrogen-bond dynamics in aqueous electrolyte solutions , 2000, Physical review letters.

[55]  P. Pedersen,et al.  Defective protein folding as a basis of human disease. , 1995, Trends in biochemical sciences.

[56]  Ehud Gazit,et al.  Inhibition of Amyloid Fibril Formation by Polyphenols: Structural Similarity and Aromatic Interactions as a Common Inhibition Mechanism , 2006, Chemical biology & drug design.

[57]  Sandip Paul,et al.  Trimethylamine-N-oxide's effect on polypeptide solvation at high pressure: a molecular dynamics simulation study. , 2013, The journal of physical chemistry. B.

[58]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[59]  K. Kubota,et al.  Inhibitory effects of choline-O-sulfate on amyloid formation of human islet amyloid polypeptide , 2012, FEBS open bio.

[60]  P E Fraser,et al.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.

[61]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[62]  Ruth Nussinov,et al.  Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States , 2011, Biochemistry.

[63]  Ruth Nussinov,et al.  Single mutations in tau modulate the populations of fibril conformers through seed selection. , 2014, Angewandte Chemie.

[64]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[65]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[66]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[67]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[68]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[69]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..